Keyphrases
After Injection
40%
Antiarrhythmic Agents
20%
Antiarrhythmic Drugs
20%
Antiarrhythmic Therapy
20%
Arrhythmia
80%
Beta-adrenergic Blockers
20%
Beta-blockers
40%
Bidirectional Ventricular Tachycardia
20%
Bruce Protocol
20%
Ca2+ Channel Blockers
20%
Ca2+ Release
20%
Calcium Channel Blockers
20%
Calsequestrin
100%
CASQ2
60%
Catecholaminergic Polymorphic Ventricular Tachycardia
100%
Catecholamines
20%
Class I Antiarrhythmics
20%
Complex Ventricular Arrhythmias
20%
Delayed Afterdepolarization
20%
Dihydropyridine
20%
Dose Effect
20%
Emotional Stress
20%
Epinephrine
20%
Exercise Duration
20%
Exercise Test
20%
Fatal Arrhythmia
20%
Flecainide
20%
Heart Rhythm
20%
Highly Effective
20%
Human Patients
40%
Lidocaine
20%
Maximum Tolerated Dose
20%
Murine Heart
20%
Mutant Mice
100%
Nifedipine
20%
Physical Stress
20%
Polymorphic Ventricular Tachycardia
20%
Procainamide
20%
Prolonged Exercise
20%
Propranolol
60%
Sotalol
20%
Sympathetic Stimulation
20%
Tachycardia Therapy
100%
Telemetry
20%
Treadmill Exercise
20%
Ventricular Arrhythmia
20%
Verapamil
100%
Pharmacology, Toxicology and Pharmaceutical Science
Antiarrhythmic Activity
20%
Antiarrhythmic Agent
60%
Beta Adrenergic Receptor Blocking Agent
20%
Calcium Channel
20%
Calcium Channel Blocker
20%
Calcium Ion
20%
Calsequestrin
100%
Catecholamine
20%
Catecholaminergic Polymorphic Ventricular Tachycardia
100%
Channel Blocker
20%
Dihydropyridine
20%
Epinephrine
20%
Flecainide
20%
Heart Arrhythmia
100%
Heart Ventricle Arrhythmia
40%
Lidocaine
20%
Maximum Tolerated Dose
20%
Mouse
20%
Mouse Mutant
100%
Nifedipine
20%
Polymorphic Ventricular Tachycardia
20%
Procainamide
20%
Propranolol
60%
Sotalol
20%
Verapamil
100%